nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals
|
Dang, Qiang |
|
2015 |
9 |
7 |
p. 1241-1251 11 p. |
artikel |
2 |
Comprehensive analysis of microRNA expression profile in malignant glioma tissues
|
Piwecka, Monika |
|
2015 |
9 |
7 |
p. 1324-1340 17 p. |
artikel |
3 |
Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4+ cells in vivo
|
Wang, Zhaohui |
|
2015 |
9 |
7 |
p. 1458-1470 13 p. |
artikel |
4 |
Editorial Board
|
|
|
2015 |
9 |
7 |
p. ii- 1 p. |
artikel |
5 |
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer
|
Foukakis, Theodoros |
|
2015 |
9 |
7 |
p. 1384-1391 8 p. |
artikel |
6 |
Instability of a dinucleotide repeat in the 3′-untranslated region (UTR) of the microsomal prostaglandin E synthase-1 (mPGES-1) gene in microsatellite instability-high (MSI-H) colorectal carcinoma
|
Cherukuri, Durga Prasad |
|
2015 |
9 |
7 |
p. 1252-1258 7 p. |
artikel |
7 |
KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells
|
Leiser, Dominic |
|
2015 |
9 |
7 |
p. 1434-1446 13 p. |
artikel |
8 |
KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer
|
Deng, Yanhong |
|
2015 |
9 |
7 |
p. 1341-1347 7 p. |
artikel |
9 |
Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation
|
Reyes-Reyes, E. Merit |
|
2015 |
9 |
7 |
p. 1392-1405 14 p. |
artikel |
10 |
MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth
|
Aakula, Anna |
|
2015 |
9 |
7 |
p. 1287-1300 14 p. |
artikel |
11 |
miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours
|
Ihle, Michaela Angelika |
|
2015 |
9 |
7 |
p. 1421-1433 13 p. |
artikel |
12 |
Natural product (−)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1
|
Lan, Lan |
|
2015 |
9 |
7 |
p. 1406-1420 15 p. |
artikel |
13 |
Pathway-based personalized analysis of breast cancer expression data
|
Livshits, Anna |
|
2015 |
9 |
7 |
p. 1471-1483 13 p. |
artikel |
14 |
Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR
|
Hou, Junwei |
|
2015 |
9 |
7 |
p. 1312-1323 12 p. |
artikel |
15 |
Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma
|
Oden, Felix |
|
2015 |
9 |
7 |
p. 1348-1358 11 p. |
artikel |
16 |
Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth
|
Dilwali, Sonam |
|
2015 |
9 |
7 |
p. 1359-1370 12 p. |
artikel |
17 |
Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms
|
Schouten, Philip C. |
|
2015 |
9 |
7 |
p. 1274-1286 13 p. |
artikel |
18 |
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
|
Woan, K.V. |
|
2015 |
9 |
7 |
p. 1447-1457 11 p. |
artikel |
19 |
Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation
|
Zhang, Hailong |
|
2015 |
9 |
7 |
p. 1301-1311 11 p. |
artikel |
20 |
Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion
|
van der Wijst, Monique G.P. |
|
2015 |
9 |
7 |
p. 1259-1273 15 p. |
artikel |
21 |
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma
|
Cheung, Belamy B. |
|
2015 |
9 |
7 |
p. 1484-1500 17 p. |
artikel |
22 |
Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma
|
Stanam, Aditya |
|
2015 |
9 |
7 |
p. 1371-1383 13 p. |
artikel |